Vivani Medical VANI Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration at other companies
Other financials
Where this comes from
Reported directly by Vivani Medical in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration.
The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vivani Medical's deferred tax assets operating loss carryforwards subject to expiration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vivani Medical's deferred tax assets operating loss carryforwards subject to expiration?
- Vivani Medical (VANI) reported deferred tax assets operating loss carryforwards subject to expiration of $47.35M in Q4 2025.
- What is the long-term trend for Vivani Medical's deferred tax assets operating loss carryforwards subject to expiration?
- Over 2 years (2023 to 2025), Vivani Medical's deferred tax assets operating loss carryforwards subject to expiration has grown at a 0.0% compound annual growth rate (CAGR), from $47.35M to $47.35M.
- What does deferred tax assets operating loss carryforwards subject to expiration mean?
- This represents the tax benefit available to the company from past operating losses that can be applied to reduce future taxable income, subject to specific expiration dates. It is a critical indicator of the potential for future tax savings, particularly for companies with a history of research-heavy, loss-making operations.